These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2707924)

  • 21. Pharmacokinetics of azithromycin in patients with impaired hepatic function.
    Mazzei T; Surrenti C; Novelli A; Crispo A; Fallani S; Carlà V; Surrenti E; Periti P
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():57-63. PubMed ID: 8396098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of paracetamol in chronic liver disease.
    Arnman R; Olsson R
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):283-6. PubMed ID: 696204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis.
    Mazzei T; Surrenti C; Novelli A; Biagini MR; Fallani S; Cassetta MI; Conti S; Surrenti E
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1556-9. PubMed ID: 10390202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of lamivudine in patients with impaired hepatic function.
    Johnson MA; Horak J; Breuel P
    Eur J Clin Pharmacol; 1998 Jun; 54(4):363-6. PubMed ID: 9696966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of temocapril, an ACE inhibitor with preferential biliary excretion, in patients with impaired liver function.
    Furuta S; Kiyosawa K; Higuchi M; Kasahara H; Saito H; Shioya H; Oguchi H
    Eur J Clin Pharmacol; 1993; 44(4):383-5. PubMed ID: 8513851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of diacerein in patients with liver cirrhosis.
    Magnard O; Louchahi K; Tod M; Petitjean O; Molinier P; Berdah L; Perret G
    Biopharm Drug Dispos; 1993 Jul; 14(5):401-8. PubMed ID: 8218958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of lidocaine after intravenous and oral administration in patients with liver cirrhosis].
    Fuchshofen M; Zilly W; Epping J; Richter E
    Verh Dtsch Ges Inn Med; 1978; (84):1110-2. PubMed ID: 741898
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacokinetics of intravenous ciprofloxacin 400 mg 12 hourly in patients with severe sepsis: the effect of renal function and intra-abdominal disease.
    Jones EM; McMullin CM; Hedges AJ; Lovering AM; White LO; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1997 Jul; 40(1):121-4. PubMed ID: 9249215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of mefenamic acid in patients with liver cirrhosis].
    Tkaczewski W; Adamska-Dyniewska H; Gajewska B; Kowalczyk L
    Pol Tyg Lek; 1978 Dec; 33(52):1997-9. PubMed ID: 733631
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral antimicrobial agents in patients with short bowel syndrome: worth a try!
    Korzilius JW; Gompelman M; Wezendonk GTJ; Jager NGL; Rovers CP; Brüggemann RJM; Wanten GJA
    J Antimicrob Chemother; 2023 Aug; 78(8):2008-2014. PubMed ID: 37390353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.
    Schlender JF; Teutonico D; Coboeken K; Schnizler K; Eissing T; Willmann S; Jaehde U; Stass H
    Clin Pharmacokinet; 2018 Dec; 57(12):1613-1634. PubMed ID: 29737457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
    Iqbal Z; Khan A; Naz A; Khan JA; Khan GS
    Clin Drug Investig; 2009; 29(4):275-81. PubMed ID: 19301941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
    Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
    Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD.
    Kowalsky SF; Echols M; Schwartz MT; Bailie GR; McCormick E
    Clin Nephrol; 1993 Jan; 39(1):53-8. PubMed ID: 8428409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.